Clinical Trials
<ѻýҕl>Slippery Slope: Diet Drugs No Help for Heartѻýҕl>
In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, ѻýҕl and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.
Apr 19, 2015
<ѻýҕl>Droxidopa for OH Slammed by FDA Reviewersѻýҕl>
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014